EstroFlavone™
Comprehensive Nutritional Support During Menopause
Price: $39.99 (USA Only)

DESCRIPTION
EstroFlavone™ capsules, provided by Advanced Medical Nutrition Inc., contain hesperidin methyl chalcone, concentrated soy isoflavones, and black cohosh root and rhizome extract, standardized to contain a minimum of 2.5% triterpenes.
FUNCTIONS
Hesperidin Methyl Chalcone: Hesperidin methyl chalcone is a methylated derivative of the flavonoid hesperidin. Hesperidin methylchalcone supports and protects the integrity of the vascular system with particular activity in the capillaries and veins.
Soy Isoflavone Concentrate: Isoflavones are a class of phytoestrogens — plant-derived compounds that are similar in structure and/or function to animal estrogens. In plants, isoflavones are bound to glycosides.
Black Cohosh: Black cohosh extract is quickly gaining popularity as a natural way to moderate and balance hormone levels. The active constituents of black cohosh appear to regulate estrogen levels, thereby normalizing hormonal balance and moderating the symptoms that accompany fluctuating hormone levels.
As with other estrogenic compounds, the active constituents in black cohosh extract may have beneficial effects in the cardiovascular and skeletal systems of postmenopausal women. As such, black cohosh offers a safe and natural method of balancing fluctuating hormone levels and easing the resulting symptoms that can occur during menopause
INDICATIONS
EstroFlavone™ may be a beneficial component of the nutritional support program of women who wish to assist hormone balance and support the health of blood vessels and capillaries during menopause.
Each capsule contains:
Hesperidin Methyl Chalcone 250 mg*
Soy Isoflavone Concentrate (NovaSoy®,
min. 40% isoflavones) 100 mg*
Black Cohosh (Cimicifuga racemosa)
Root and rhizome, dried extract, min. 2.5%
terpenes 40 mg*
*Daily Value not established
Other Ingredients: Gelatin, cellulose, water, and magnesium stearate.
SUGGESTED USE
1 to 2 capsules daily with meals or as directed by physician. It is recommended that prolonged use of black cohosh beyond six months be under physician supervision.
SIDE EFFECTS
The ingredients in EstroFlavone are well-tolerated and do not generally cause side effects. Use of black cohosh extract is not recommended during pregnancy or lactation.

HOW SUPPLIED
Bottles contain 60 capsules. Packed 12 bottles per case.
STORAGE
Store in a cool, dry place, away from direct light. Keep out of reach of children.
REFERENCES
Adlercreutz H, Mousavi Y, Clark J, et al. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid biochem Mol Biol 1992;41:331-7.
Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5.
Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80:1685-90.
Barnes S, Peterson TG. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med 1995;208:103-8.
Beuscher, N. Cimicifuga racemosa L.- Black Cohosh. Quarterly Review
of Natural Medicine Spring 1996.
Beaugerie L, Luboinski J, Brousse N, et al. Drug induced lymphocyctic
colitis. Gut 1994;35(3):426-8.
Bouskela E, Cyrino FZGA, Marcelon G, et al. Inhibitory effect of the
Ruscus Extract and of the flavonoid hesperidin methylchalcone on
increased microvascular permeability. J Cardiovasc Pharmacol
1993;22:225-230.
Chanal JL, Cousse H, Sicart MT, et al. Absorption and elimination of
carbon-14 labeled hesperidin methyl chalcone in the rat. Eur J Drug
Metab Pharmacokinet 1981;6:171-178.
Cluzan RV, Alliot F, Ghabboun S, et al. Treatment of secondary
lymphedema of the upper limb with CYCLO 3 FORT. Lymphology
1996;29:29-35.
Constantinou A, Huberman E. Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc Soc Exp Biol Med 1995;208:109-15.
Coope J. Hormonal and non-hormonal interventions for menopausal
symptoms. Maturitas 1996;23:159-68.
Domange JR, Bougaret S, Yubero L. Pharmacological studies of Cyclo 3
Fort and its constituents (Ruscus extract, hesperidin methyl chalcone,
ascorbic acid): An up to date review. Clinical Hemorheology
1994;14:S7-S13.
Duker EM, Kopanski L, Jarry H, Wuttke E. Effects of extracts from
Cimicifuga racemosa on gonadotropin release in menopausal women
and ovarectomized rats. Planta Medica 1991;57:420-4.
Gooderham MH, Adlercreutz H, Ojala ST, et al. A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentration, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J Nutr 1996;126:2000-6.
Hodgson JM, Puddey IB, Beilin LJ, et al. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr 1998;128:728-32.
Hsieh CY, Snatell RC, Haslam SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptof-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998;58:3833-8.
Ingram, D, Sanders, K, Kolybaba, M, et. al. Case-control study of
phytoestrogens and breast cancer. Lancet 1997;350:990-994.
Kawabe M, Tamano S, Shibata MA, et al. Subchronic toxicity study of
methyl hesperidin in mice. Toxicol Lett 1993 Jul;69(1):37-44.
Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996;87:897-904.
Kurata Y, Fukushima S, Hagiwara A, et al. Carcinogenicity study of methyl
hesperidin in B6C3F1 mice. Food Chem Toxicol 1990 Sep;28(9):613-8.
Lieberman S. A review of the effectiveness of Cimicifuga racemosa (black
cohosh) for the symptoms of menopause. Journal of Womens Health
1998;7:525-9.
Lock M. Menopause: lessons from anthropology. Psychosomatic Medicine
1998;60:410-9.
Nagata C, Takatsuka N, Kurisu Y, Shimizu H. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 1998;128:209-213.
Rudofsky G. [Improving venous tone and capillary sealing. Effect of a
combination of Ruscus extract and herperidine methyl chalcone in
healthy probands in heat stress]. Fortschr Med 1989;107:55-8.
Ruiz-Larrea MB, Mohan AR, Paganga G, et al. Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res 1997;26:63-70.
Svensjo E, Bouskela E, Cyrino FZ, Bougaret S. Antipermeability effects of
Cyclo 3 Fort in hamsters with moderate diabetes. Clin Hemorheol
Microcirc 1997;17(5):385-8.
Thomas-Anterion C, Guy C, Vial F, et al. [Unexplained chronic diarrhea,
apropos of 4 new cases under Cyclo 3 Fort and review of literature].
Rev Med Interne 1993;14(4):215-7.
Wang C, Kurzer MS. Phytoestrogen concentration determines effect on DNA synthesis in human breast cancer cells. Nutr Cancer 1997;28:236-47.
Xu X, Duncan AM, Merz BE, Kurzer MS. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev 1998;7:1101-8.
Yamaguchi M, Gao YH. Inhibitory effect of genistein on bone resorption in tissue culture. Biochem Pharmacol 1998;55:71-6.
Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 1997;27:31-40.
Zheng, QY. A novel botanical extract for menopausal women. Madis
Botanicals, Inc. 1997.